Loading...
Ce produit n'est pas destiné à diagnostiquer, traiter, guérir ou prévenir toute maladie. Ces déclarations n'ont pas été évaluées par la Food and Drug Administration.
Loading...
Ces informations sont fournies à titre éducatif uniquement et ne remplacent pas un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours votre professionnel de santé avant d'utiliser des plantes, surtout si vous êtes enceinte, allaitez, prenez des médicaments ou avez une condition médicale.
Trifolium pratense isoflavones
Concentrated isoflavone extract from red clover specifically formulated for menopausal symptom management with multiple clinical trials.
Red clover isoflavones (Trifolium pratense) are concentrated phytoestrogenic extracts standardized to isoflavones like formononetin and biochanin A, primarily used for menopausal symptom management including hot flash reduction and bone density support. Multiple clinical trials support its efficacy, though results vary due to individual differences in gut microbiota metabolism. Key active compounds include daidzein, genistein, and equol precursors.
Isoflavones act as selective estrogen receptor modulators (SERMs), binding preferentially to estrogen receptor beta (ERβ) over ERα, exerting weak estrogenic effects in bone and vasculature while potentially antagonizing estrogen in breast tissue. Formononetin is metabolized to daidzein and then to equol, a more potent metabolite, by gut microbiota, explaining interindividual variability. They also inhibit tyrosine kinases and modulate NF-κB pathways, contributing to anti-inflammatory and antioxidant effects.
Concentrated isoflavone extract from red clover specifically formulated for menopausal symptom management with multiple clinical trials.
Red clover isoflavones (Trifolium pratense) are concentrated phytoestrogenic extracts standardized to isoflavones like formononetin and biochanin A, primarily used for menopausal symptom management including hot flash reduction and bone density support. Multiple clinical trials support its efficacy, though results vary due to individual differences in gut microbiota metabolism. Key active compounds include daidzein, genistein, and equol precursors.
Isoflavones act as selective estrogen receptor modulators (SERMs), binding preferentially to estrogen receptor beta (ERβ) over ERα, exerting weak estrogenic effects in bone and vasculature while potentially antagonizing estrogen in breast tissue. Formononetin is metabolized to daidzein and then to equol, a more potent metabolite, by gut microbiota, explaining interindividual variability. They also inhibit tyrosine kinases and modulate NF-κB pathways, contributing to anti-inflammatory and antioxidant effects.